Rasulov M M, Velikaia M V, Zabozlaev A G, Kuznetsov I G, Voronkov M G
Biull Eksp Biol Med. 1993 Nov;116(11):460-2.
The data obtained showed that the polysaccharide diminished the blood levels of cholesterol, beta-lipoproteins, and triglycerides, the concentrations of cholesterol in the liver and thoracic aorta in experimental atherosclerosis. It is concluded that the polysaccharide is promising in designing a new anti-atherosclerotic drug.
所获得的数据表明，该多糖可降低胆固醇、β-脂蛋白和甘油三酯的血液水平，以及实验性动脉粥样硬化中肝脏和胸主动脉中的胆固醇浓度。得出的结论是，该多糖在设计新型抗动脉粥样硬化药物方面具有前景。
